A Double Blinded Study of the Effect on Post-prandial Glycemia, Safety, and Tolerability of VIAject vs. Lispro Insulin during Subcutaneous Insulin Pump Therapy
Phase of Trial: Phase III
Latest Information Update: 06 Aug 2015
At a glance
- Drugs Insulin (Primary) ; Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics; Registrational
- Sponsors Biodel
- 01 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Apr 2010 Planned number of patients (24) and actual initiation date (Jun 2010) added as reported by ClinicalTrials.gov.
- 28 Apr 2010 New source identified and integrated (ClinicalTrials.gov record no. NCT01110746).